NCT07645989 Registry of Outcomes of Dezawa MuseCells®
| NCT ID | NCT07645989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MuseCell Innovations Pte LTD |
| Condition | Osteoarthritis (OA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2031-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2026-07-01 with a primary completion date of 2031-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases. The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.
Eligibility Criteria
Inclusion Criteria: 1. Received Dezawa MuseCells® as Part of Routine Clinical Care 2. Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up. 3. Willingness to Complete Online Survey Assessments 4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period. 5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions. 6. Ability to Communicate in the Registry's Supported Language 7. Participants must be able to read and respond to registry surveys in the designated study language. 8. Enrollment Within 12 Months of MuseCell® Administration Exclusion Criteria: 1. Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included. 2. Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf. 3. Inability to Participate in Long-Term Digital Follow-Up 4. Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes 5. History of Malignancy Diagnosed Within the Past 12 Months 6. Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns. 7. Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality 8. Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods. 9. Pregnant or Actively Breastfeeding at Time of Enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07645989 clinical trial?
This trial is open to participants of all sexes, up to 89 Years, studying Osteoarthritis (OA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07645989 currently recruiting?
Yes, NCT07645989 is actively recruiting participants. Contact the research team at info@musecellinnovations.com for enrollment information.
Where is the NCT07645989 trial being conducted?
This trial is being conducted at North Palm Beach, United States, Guadalajara, Mexico.
Who is sponsoring the NCT07645989 clinical trial?
NCT07645989 is sponsored by MuseCell Innovations Pte LTD. The trial plans to enroll 5,000 participants.